Related Experiment Video
Updated: Jan 21, 2026

Profiling Ubiquitin and Ubiquitin-like Dependent Post-translational Modifications and Identification of Significant Alterations
Published on: November 7, 2019
DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation
Haoran Cui1, Qin Wang2, Zhenchuan Lei3
1Department of Cell Biology and Key Laboratory of Experimental Teratology, Ministry of Education, Shandong University School of Medicine, Jinan, Shandong, China.
Background:
Ubiquitin E3 ligase CUL4A plays important oncogenic roles in the development of cancers. DTL, one of the CUL4-DDB1 associated factors (DCAFs), may involve in the process of cancer development. Programmed cell death 4 (PDCD4) is a tumor suppressor gene involved in cell apoptosis, transformation, invasion and tumor progression.
Methods:
Affinity-purification mass spectrometry was used to identify potential DTL interaction proteins. Co-immunoprecipitation (Co-IP) was performed to verify protein interaction between DTL and PDCD4. mRNA levels in cancer cells and tissues were detected by Quantitative real-time PCR. Lentivirus was used to establish stable overexpression and knocking down cell lines for DTL and PDCD4. Transwell and wound healing assays were used to determine migration ability of cancer cells. Matrigel assay was used to determine invasion ability of cancer cells. MTT and colony formation assays were used to evaluate proliferation of cancer cells.
Results:
In this study, programmed cell death 4 (PDCD4) was identified as a potential substrate of DTL. Co-IP and immunofluorescence assays further confirmed the interaction between DTL and PDCD4. Moreover, DTL overexpression decreased the protein level and accelerated the degradation rate of PDCD4. Through in vitro ubiquitination experiment, we proved that PDCD4 was degraded by DTL through ubiquitination. Clinically DTL was significantly up-regulated in cancer tissues than that in normal tissues. The survival curves showed that cancer patients with higher DTL expression owned lower survival rate. Functional experiments showed that DTL not only enhanced the proliferation and migration abilities of cancer cells, but also promoted the tumorigenesis in nude mice. Rescued experiment results demonstrated that silencing PDCD4 simultaneous with DTL recovered the phenotypes defect caused by DTL knocking down.
Conclusions:
Our results elucidated that DTL enhanced the motility and proliferation of cancer cells through degrading PDCD4 to promote the development of cancers.
Insights
The study reveals that DTL degrades the tumor suppressor PDCD4 (Programmed cell death 4), promoting cancer cell proliferation and migration. This finding highlights DTL as a potential therapeutic target in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The ubiquitin E3 ligase CUL4A is implicated in cancer development.
- DTL, a CUL4-DDB1 associated factor (DCAF), may play a role in oncogenesis.
- Programmed cell death 4 (PDCD4) is a tumor suppressor involved in apoptosis and tumor progression.
Purpose of the Study:
- To investigate the role of DTL in cancer development.
- To identify PDCD4 as a potential substrate of DTL.
- To elucidate the mechanism by which DTL influences cancer cell behavior.
Main Methods:
- Affinity-purification mass spectrometry and Co-immunoprecipitation (Co-IP) to identify and verify protein interactions.
- Quantitative real-time PCR to assess mRNA levels.
- Lentivirus-mediated gene manipulation (overexpression and knockdown) to study gene function.
- In vitro ubiquitination assays to determine degradation mechanisms.
- Transwell, wound healing, Matrigel, MTT, and colony formation assays to evaluate cell migration, invasion, and proliferation.
- Tumorigenesis assays in nude mice.
Main Results:
- PDCD4 was identified as a substrate of DTL, with DTL accelerating PDCD4 degradation via ubiquitination.
- DTL overexpression decreased PDCD4 protein levels and enhanced cancer cell proliferation, migration, and invasion.
- DTL was significantly upregulated in cancer tissues, correlating with lower patient survival rates.
- Silencing PDCD4 reversed the DTL-induced cancer cell phenotypes.
Conclusions:
- DTL promotes cancer development by degrading the tumor suppressor PDCD4.
- DTL enhances cancer cell motility and proliferation.
- DTL represents a potential therapeutic target for cancer treatment.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Regulated Protein Degradation
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA...
Proteins: From Genes to Degradation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Eukaryotic Promoter Region

